Bookmark and Share

Major Movers on January 11; DNDN, BBY, KBR, INFY, ARQL, JCP, WFC

Shares of Dendreon Corporation (NASDAQ: DNDN) rallied on Friday after analysts at Bernstein Research boosted its rating on the pharmaceutical company to “outperform” and raised its price target on stock by 43% to $10, citing upbeat outlook on company’s prostate cancer treatment. The 52-week trading of the stock is $5.73-$6.02.

[...]

Bookmark and Share

Dendreon Shares Surge on Rating Upgrade (DNDN)

Shares of Dendreon Corporation (NASDAQ: DNDN), a biotechnology company engaged in the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients, are seeing a huge rally in trading today following a rating upgrade from Sanford C. Bernstein.

[...]


-------------------------------------------------------------------------------------------------------------------------
All stories in DailyStocks.com are for informational purposes only. This is NOT a stock recommendation. This DailyStocks.com story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at DailyStocks.com . About Dailystocks.com: DailyStocks.com is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.